Bojahr B, Straube W, Reddemann H
Klinik, Ernst-Moritz-Arndt-Universität Greifswald.
Zentralbl Gynakol. 1993;115(3):125-8.
At three patients who have been operated on because of completely different tumours (trophoblast tumour, endodermalsinus tumour of the right ovary and rhabdomyosarcoma as well as adrenal cortex carcinoma) pre-operatively the Early Pregnancy Factor (EPF) could in each case be shown in the serum with the help of the rosette inhibition test. In two cases the EPF already intra-operatively disappeared from the serum. In the third case it could be found until the second day after operation. Since that patient suffered from two histogenetically non-related malignant tumours it was not possible to trace whether the adrenal cortex carcinoma or the rhabdomyosarcoma have been the reason for the EPF-synthesis. The already intra-operative disappearance and the also during further post-operative controls unsuccessful proof of EPF in serum can indicate an opportunity for the early assessment of efficiency of the surgical treatment of tumours which develop EPF or which induce the EPF-synthesis.
有三名患者因完全不同的肿瘤(滋养层肿瘤、右卵巢内胚窦瘤和横纹肌肉瘤以及肾上腺皮质癌)接受了手术,术前借助玫瑰花结抑制试验均能在血清中检测到早期妊娠因子(EPF)。其中两例患者在手术过程中血清中的EPF就已消失。第三例患者在术后第二天仍能检测到。由于该患者患有两种组织发生学上不相关的恶性肿瘤,因此无法确定是肾上腺皮质癌还是横纹肌肉瘤导致了EPF的合成。手术过程中EPF的消失以及术后进一步检查血清中EPF检测呈阴性,这可能为早期评估产生EPF或诱导EPF合成的肿瘤的手术治疗效果提供了一个契机。